PMID- 36456139 OWN - NLM STAT- MEDLINE DCOM- 20221205 LR - 20221205 IS - 1791-7530 (Electronic) IS - 0250-7005 (Linking) VI - 42 IP - 12 DP - 2022 Dec TI - The Expression of Histone Acetyltransferase KAT6A in Non-small Cell Lung Cancer. PG - 5731-5741 LID - 10.21873/anticanres.16080 [doi] AB - BACKGROUND/AIM: KAT6A is considered a factor influencing carcinogenesis. Due to the fact that lung cancer is one of the leading causes of death, the aim of our study was to evaluate KAT6A expression in non-small cell lung cancer (NSCLC) tumors and the NSCLC cell line model. MATERIALS AND METHODS: The expression of KAT6A was examined in NSCLC tumors by real-time PCR and immunohistochemistry. KAT6A expression was investigated in the NSCLC cell line model by real-time PCR, western blot, and immunofluorescence. RESULTS: KAT6A protein level was elevated in NSCLC tumors compared to non-malignant lung tissues (NMLT). The KAT6A mRNA expression in NSCLC, lung adenocarcinoma, and lung squamous cell carcinoma samples was differentiated. The results from the in vitro NSCLC model demonstrated elevated expression of KAT6A in lung cancer cell lines in comparison to normal lung fibroblasts. CONCLUSION: The outcomes showed an increased KAT6A protein level in NSCLC compared to control samples, which suggests the oncogenic role of KAT6A in this type of cancer. Therefore, targeting KAT6A in NSCLC might be worth consideration. CI - Copyright (c) 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. FAU - Partynska, Aleksandra AU - Partynska A AD - Division of Histology and Embryology, Department of Human Morphology and Embryology, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland; aleksandra.partynska@umw.edu.pl. FAU - Piotrowska, Aleksandra AU - Piotrowska A AD - Division of Histology and Embryology, Department of Human Morphology and Embryology, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland. FAU - Pawelczyk, Konrad AU - Pawelczyk K AD - Lower Silesian Oncology, Pulmonology and Haematology Centre, Wroclaw, Poland. FAU - Rzechonek, Adam AU - Rzechonek A AD - Department of Thoracic Surgery, Wroclaw Medical University, Wroclaw, Poland. FAU - Ratajczak-Wielgomas, Katarzyna AU - Ratajczak-Wielgomas K AD - Division of Histology and Embryology, Department of Human Morphology and Embryology, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland. FAU - Podhorska-Okolow, Marzenna AU - Podhorska-Okolow M AD - Division of Ultrastructural Research, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland. AD - Division of Human Biology, Faculty of Physiotherapy, Wroclaw University of Health and Sport Sciences, Wroclaw, Poland. FAU - Dziegiel, Piotr AU - Dziegiel P AD - Division of Histology and Embryology, Department of Human Morphology and Embryology, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland. AD - Division of Human Biology, Faculty of Physiotherapy, Wroclaw University of Health and Sport Sciences, Wroclaw, Poland. LA - eng PT - Journal Article PL - Greece TA - Anticancer Res JT - Anticancer research JID - 8102988 RN - EC 2.3.1.48 (Histone Acetyltransferases) RN - EC 2.3.1.48 (KAT6A protein, human) SB - IM MH - Humans MH - *Carcinoma, Non-Small-Cell Lung/genetics MH - *Lung Neoplasms/genetics MH - Histone Acetyltransferases/genetics MH - *Adenocarcinoma of Lung MH - Oncogenes MH - Carcinogenesis OTO - NOTNLM OT - KAT6A OT - lysine acetyltransferase OT - non-small cell lung cancer EDAT- 2022/12/02 06:00 MHDA- 2022/12/06 06:00 CRDT- 2022/12/01 21:13 PHST- 2022/09/27 00:00 [received] PHST- 2022/10/11 00:00 [revised] PHST- 2022/10/12 00:00 [accepted] PHST- 2022/12/01 21:13 [entrez] PHST- 2022/12/02 06:00 [pubmed] PHST- 2022/12/06 06:00 [medline] AID - 42/12/5731 [pii] AID - 10.21873/anticanres.16080 [doi] PST - ppublish SO - Anticancer Res. 2022 Dec;42(12):5731-5741. doi: 10.21873/anticanres.16080.